Cited by 30Cancer-related Molecular PathwaysUbiquitin and proteasome pathwaysGenomics and Chromatin Dynamics

Tumor suppressor protein Pdcd4 interacts with Daxx and modulates the stability of Daxx and the Hipk2-dependent phosphorylation of p53 at serine 46

Open access
Kumar, N, Wethkamp, N, Waters, L C, Carr, M D, Klempnauer, K-H·2013·Oncogenesis

Abstract

The tumor suppressor protein Pdcd4 is a nuclear/cytoplasmic shuttling protein that has been implicated in the development of several types of human cancer. In the nucleus, Pdcd4 affects the transcription of specific genes by modulating the activity of several transcription factors. We have identified the Daxx protein as a novel interaction partner of Pdcd4. Daxx is a scaffold protein with roles in diverse processes, including transcriptional regulation, DNA-damage signaling, apoptosis and chromatin remodeling. We show that the interaction of both proteins is mediated by the N-terminal domain of Pdcd4 and the central part of Daxx, and that binding to Pdcd4 stimulates the degradation of Daxx, presumably by disrupting the interaction of Daxx with the de-ubiquitinylating enzyme Hausp. Daxx has previously been shown to serve as a scaffold for protein kinase Hipk2 and tumor suppressor protein p53 and to stimulate the phosphorylation of p53 at serine 46 (Ser-46) in response to genotoxic stress. We show that Pdcd4 also disrupts the Daxx-Hipk2 interaction and inhibits the phosphorylation of p53. We also show that ultraviolet irradiation decreases the expression of Pdcd4. Taken together, our results support a model in which Pdcd4 serves to suppress the phosphorylation of p53 in the absence of DNA damage, while the suppressive effect of Pdcd4 is abrogated after DNA damage owing to the decrease of Pdcd4. Overall, our data demonstrate that Pdcd4 is a novel modulator of Daxx function and provide evidence for a role of Pdcd4 in restraining p53 activity in unstressed cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/oncsis.2012.37

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DNA damages decrease PDCD4 expression and increase phosphorylation of TP53 protein.

    “PDCD4 inhibits the phosphorylation of TP53 in the absence of DNA damage disrupting the DAXX and HIPK2 association, while DNA damages decrease the PDCD4 expression and increase the phosphorylation of TP53 protein.”
  • PDCD4 inhibits phosphorylation of TP53 in the absence of DNA damage by disrupting the DAXX and HIPK2 association.

    “PDCD4 inhibits the phosphorylation of TP53 in the absence of DNA damage disrupting the DAXX and HIPK2 association, while DNA damages decrease the PDCD4 expression and increase the phosphorylation of TP53 protein.”
  • PDCD4 may function to restrain TP53 activity in unstressed conditions.

    “Thus, PDCD4 may function to restrain TP53 activity in unstressed conditions [42].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 74 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Rinaldo C Prodosmo A Siepi F Soddu S HIPK2: a multitalented partner for transcription factors in DNA damage response and development Biochem Cell Biol 2007 85 411 418 17713576

Cited by

Sorted by citations

Authors
Kumar, N., Wethkamp, N., Waters, L. C., Carr, M. D., & Klempnauer, K.-H.
Affiliations
  • University of Münster (DE)
  • University of Leicester (GB)
Corresponding author
Klempnauer, K-H
Venue
Oncogenesis
Published
2013-01-14
Volume
2
Issue
1
Pages
e37-e37
ISSN
2157-9024 (ISSN-L)
OpenAlex
W2133221120
Cited by
30
References
74
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 1 · 2021: 1 · 2020: 5 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 6
FWCI
1.61
Type
journal article
Language
en
Open access
Locations
  • Oncogenesis (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
  • Leicester Research Archive (University of Leicester) (submittedVersion, cc-by-nc-nd)
Funders
  • Wellcome Trust
  • Deutsche Krebshilfe
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
PDCD4, DAXX, HIPK2, protein-protein interaction, protein stability, protein degradation, DNA damage response, UV irradiation, tumor suppressor, transcriptional regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review